Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Y Yu

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Cancer Cell International|July 10, 2018
miR-133a function in the pathogenesis of dedifferentiated liposarcomaPeter Y Yu, Gonzalo Lopez, Danielle Braggio, et al.
Plos One|July 28, 2017
Target specificity, in vivo pharmacokinetics, and efficacy of the putative STAT3 inhibitor LY5 in osteosarcoma, Ewing's sarcoma, and rhabdomyosarcomaPeter Y Yu, Heather L Gardner, Ryan Roberts, et al.
Iscience|August 13, 2025
MyoD is essential in rhabdomyosarcoma by promoting survival through differentiation and CYLDAlexander R Oles, Peter Y Yu, Abasi-Ama Udeme, et al.
The Journal of Surgical Research|October 4, 2018
Perioperative chemotherapy is not associated with improved survival in high-grade truncal sarcomaPeter Y Yu, Eliza W Beal, Tasha M Hughes, et al.
Journal of Surgical Oncology|April 2, 2020
Neoadjuvant radiation improves margin-negative resection rates in extremity sarcoma but not survivalRita D Shelby, Lorena P Suarez-Kelly, Peter Y Yu, et al.
The Journal of Surgical Research|September 9, 2019
Trends in the Use of Adjuvant Chemotherapy for High-Grade Truncal and Extremity Soft Tissue SarcomasMalcolm H Squires, Cecilia G Ethun, Lorena P Suarez-Kelly, et al.
The American Surgeon|November 11, 2021
Resection Status Does Not Impact Recurrence in Well-Differentiated Liposarcoma of the ExtremityChelsea R Olson, Lorena P Suarez-Kelly, Cecilia G Ethun, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Cancer Cell International|July 10, 2018
miR-133a function in the pathogenesis of dedifferentiated liposarcomaPeter Y Yu, Gonzalo Lopez, Danielle Braggio, et al.
Plos One|July 28, 2017
Target specificity, in vivo pharmacokinetics, and efficacy of the putative STAT3 inhibitor LY5 in osteosarcoma, Ewing's sarcoma, and rhabdomyosarcomaPeter Y Yu, Heather L Gardner, Ryan Roberts, et al.
Iscience|August 13, 2025
MyoD is essential in rhabdomyosarcoma by promoting survival through differentiation and CYLDAlexander R Oles, Peter Y Yu, Abasi-Ama Udeme, et al.
The Journal of Surgical Research|October 4, 2018
Perioperative chemotherapy is not associated with improved survival in high-grade truncal sarcomaPeter Y Yu, Eliza W Beal, Tasha M Hughes, et al.
Journal of Surgical Oncology|April 2, 2020
Neoadjuvant radiation improves margin-negative resection rates in extremity sarcoma but not survivalRita D Shelby, Lorena P Suarez-Kelly, Peter Y Yu, et al.
The Journal of Surgical Research|September 9, 2019
Trends in the Use of Adjuvant Chemotherapy for High-Grade Truncal and Extremity Soft Tissue SarcomasMalcolm H Squires, Cecilia G Ethun, Lorena P Suarez-Kelly, et al.
The American Surgeon|November 11, 2021
Resection Status Does Not Impact Recurrence in Well-Differentiated Liposarcoma of the ExtremityChelsea R Olson, Lorena P Suarez-Kelly, Cecilia G Ethun, et al.
Pageof 2